Enhancer ID: | E_01_0597 |
Species: | human |
Position : | chr22:42123282-42125282 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | -- |
Pubmed ID: | 32457600 |
Enhancer experiment: | PCR |
Enhancer experiment description: | Results: Phasing predicted that the enhancer SNP can occur on numerous CYP2D6 haplotypes including CYP2D6*1, *2, *5, and *41 and suggested that linkage is incomplete, i.e., a portion of these alleles do not have the enhancer SNP. |
Target gene : | CYP2D6(CPD6,CYP2D,CYP2D7AP,CYP2D7BP,CYP2D7P2,CYP2D8P2,CYP2DL1,CYPIID6,P450-DB1,P450C2D,P450DB1) |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Results: Phasing predicted that the enhancer SNP can occur on numerous CYP2D6 haplotypes including CYP2D6*1, *2, *5, and *41 and suggested that linkage is incomplete, i.e., a portion of these alleles do not have the enhancer SNP. |
TF name : | -- |
TF experiment: | PCR |
TF experiment description: | Results: Phasing predicted that the enhancer SNP can occur on numerous CYP2D6 haplotypes including CYP2D6*1, *2, *5, and *41 and suggested that linkage is incomplete, i.e., a portion of these alleles do not have the enhancer SNP. |
Enhancer function : | Results: Phasing predicted that the enhancer SNP can occur on numerous CYP2D6 haplotypes including CYP2D6*1, *2, *5, and *41 and suggested that linkage is incomplete, i.e., a portion of these alleles do not have the enhancer SNP. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Results: Phasing predicted that the enhancer SNP can occur on numerous CYP2D6 haplotypes including CYP2D6*1, *2, *5, and *41 and suggested that linkage is incomplete, i.e., a portion of these alleles do not have the enhancer SNP. |
GeneName | Pathway Name | Source | Gene Number |
---|